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ABSTRACT
An RNA-dependent RNA polymerase (RdRp) is the
central catalytic subunit of the RNA-synthesizing
machinery of all positive-strand RNA viruses.
Usually, RdRp domains are readily identifiable by
comparative sequence analysis, but biochemical
confirmation and characterization can be ham-
pered by intrinsic protein properties and technical
complications. It is presumed that replication and
transcription of the  30-kb severe acute respiratory
syndrome (SARS) coronavirus (SARS-CoV) RNA
genome are catalyzed by an RdRp domain in the
C-terminal part of nonstructural protein 12 (nsp12),
one of 16 replicase subunits. However, thus far
full-length nsp12 has proven refractory to expres-
sion in bacterial systems, which has hindered both
the biochemical characterization of coronavirus
RNA synthesis and RdRp-targeted antiviral drug
design. Here, we describe a combined strategy
involving bacterial expression of an nsp12 fusion
protein and its in vivo cleavage to generate and
purify stable SARS-CoV nsp12 (106kDa) with a
natural N-terminus and C-terminal hexahistidine
tag. This recombinant protein possesses robust
in vitro RdRp activity, as well as a significant DNA-
dependent activity that may facilitate future inhibitor
studies. The SARS-CoV nsp12 is primer dependent
on both homo- and heteropolymeric templates,
supporting the likeliness of a close enzymatic col-
laboration with the intriguing RNA primase activity
that was recently proposed for coronavirus nsp8.
INTRODUCTION
The central enzymatic activity in the life cycle of
positive-strand RNA (+RNA) viruses is the process of
RNA-templated RNA synthesis. In mammalian cells, the
replication of +RNA genomes always occurs in the cyto-
plasm where the viral RNA-synthesizing machinery is
commonly associated with (modiﬁed) cytoplasmic
membranes, which presumably provide physical support
and may serve to protect the complex from host defense
mechanisms (1,2). The viral enzyme complex contains an
RNA-dependent RNA polymerase (RdRp) as its core
catalytic subunit for the production of negative strand
RNA (–RNA), new genome molecules and in many
virus groups also subgenomic (sg) messenger RNAs
(mRNAs) (1,3).
Coronaviruses (CoVs) are a family of +RNA viruses
that infect a wide range of vertebrates including humans,
as exempliﬁed by severe acute respiratory syndrome
(SARS) and various respiratory infections caused by
less-virulent family members (4). The group is also
known for its exceptionally large polycistronic genome
of  30kb, which is 50 capped and 30 polyadenylated
RNA. The 50-proximal two-thirds of the CoV genome
(open reading frames 1a and 1b) are translated into
the viral replicase polyproteins pp1a and pp1ab. The
30-proximal third encodes the viral structural proteins
and several so-called accessory proteins, which can only
be expressed following the production of a set of four to
nine sg mRNAs (5,6). In particular, it is this CoV
hallmark that has attracted attention over the years,
since these sg mRNAs consist of sequences that are
noncontiguous in the viral genome: a common 50 leader
sequence is attached to body segments representing a
variable part of the 30-proximal genomic region.
According to the now widely supported transcription
model of Sawicki and Sawicki (7), the arterivirus and
CoV sg RNAs derive from a discontinuous step during
minus-strand RNA synthesis that is guided by speciﬁc
RNA signals and resembles copy-choice RNA recombina-
tion (5,6,8). This mechanism produces a set of subgenome-
length negative-strand templates from which the sg
mRNAs are produced. The unusual genome size of
CoVs and the complexity of their RNA synthesis hint at
*To whom correspondence should be addressed. Tel: +31 71 5261657; Fax: +31 71 5266761; Email: e.j.snijder@lumc.nl
Published online 29 October 2009 Nucleic Acids Research, 2010, Vol. 38, No. 1 203–214
doi:10.1093/nar/gkp904
 The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.an RdRp that may have special properties, either by itself
or in conjunction with other subunits of the CoV replica-
tion/transcription complex (RTC).
CoV replication and transcription are driven by the 15
or 16 viral nonstructural proteins (nsps) encoded in the
replicase gene, which include many enzyme activities that
are rare or lacking in other families of +RNA viruses
(9,10). These nsps are produced during co- and post-
translational processing of the pp1a and pp1ab replicase
polyproteins by two or three internal viral proteinases
(11). In the years following the 2003 SARS outbreak,
bioinformatics, structural biology, (reverse) genetics and
biochemical studies have all contributed to the in-depth
characterization of CoV nsps in general and those of
SARS-CoV in particular (9,10,12). Currently documented
enzyme activities include proteinases (11), a putative RNA
primase (13), a superfamily 1 helicase (14), an exo- and an
endoribonuclease (15,16), single-stranded RNA (ssRNA)-
binding proteins (17,18) and two methyltransferases
(19,20). Following the sequence analysis of the ﬁrst CoV
genomes, more than two decades ago, the putative RdRp
domain of the coronavirus RTC had already been
identiﬁed by comparative sequence analysis (21,22). The
C-terminal, two-thirds of the 932-amino-acid subunit,
now known as nsp12 was conﬁdently aligned with the
conserved motifs of well-known RdRps (22,23). In view
of its unprecedented size among viral RdRp subunits,
which commonly consist of 500–600 amino acids, nsp12
may well harbor other functional domains in its as-yet
uncharacterized N-terminal domain. Biochemical infor-
mation on the CoV RdRp has, however, remained
scarce thus far, particularly since full-length nsp12 was
refractory to expression in bacterial systems. Preliminary
evidence for the in vitro RdRp activity of nsp12 came from
a study of the SARS-CoV enzyme by Cheng et al. (24).
However, their experiments, employing a glutathione
S-transferase (GST)-nsp12 fusion protein, were ham-
pered by protein instability, which resulted in the fragmen-
tation of the protein into three parts. Primer-dependent
activity on poly(A) templates was observed in ﬁlter
binding assays, but the enzyme biochemistry was not
further characterized in detail.
Given its pivotal role in viral replication and the eﬃcacy
of polymerase inhibitors used to combat other virus
infections, the SARS-CoV RdRp is widely regarded as
an important and attractive target for the rational
design of anti-CoV drugs (23,25). We therefore sought
to solve the technical issues described above and develop
reliable protocols for stable expression, puriﬁcation and
in vitro activity of the full-length CoV nsp12. In this
article, we describe an expression strategy utilizing in
vivo cleavage in a bacterial expression system by ubiquitin
carboxyl-terminal hydrolase 1 (Ubp1), which releases the
small N-terminal fusion partner ubiquitin (Ub) and
generates a recombinant nsp12 protein containing its
natural N-terminus. This was found to be a critical step
on the road toward puriﬁcation of a stable recombinant
SARS-CoV RdRp. We subsequently established that full-
length nsp12 can readily synthesize RNA in a primer-
dependent fashion on both homo- and heteropolymeric
RNA templates and is also eﬃcient at incorporating
deoxy-nucleotides on a DNA template. This work there-
fore provides a solid basis for the further biochemical
characterization of the coronavirus nsp12 and the
detailed dissection of its role in viral replication and tran-
scription. Understanding the enzyme’s properties will be
essential for the development of selective coronavirus
RdRp inhibitors and will likely provide novel insights
into the intriguing (evolutionary) relation between the
RdRp of nidoviruses and other groups of +RNA viruses.
MATERIALS AND METHODS
Cloning and expression of recombinant SARS-CoV nsp12
The amino acid sequence of SARS-CoV nsp12, residues
S4370 to Q5301 of replicase pp1ab, is fully conserved
among all sequenced SARS-CoV isolates. For our study,
the nsp12-coding region was ampliﬁed by reverse
transcription-polymerase chain reaction (RT-PCR) from
the genome of SARS-CoV Frankfurt-1 (AY291315).
During ampliﬁcation, the ORF1a/1b  1 ribosomal frame-
shift near the 50-end of the gene was corrected in a
translationally silent manner. Primers used for ampliﬁca-
tion were SAV424 50-GCGGGTACCCCGCGGTGGAT
CTGCGGATGCATCAA-30 and SAV425 50-GCGCGAT
CGGGATCCCTGCAAGACTGTATGT-30, correspond-
ing to SARS-CoV genome positions 13327–13387 and
16152–16166, respectively. The PCR amplicon was
digested with SacII and BamHI, and ligated into expres-
sion vector pET26-Ub-CHis6 (26). Following conﬁrma-
tion of the nucleotide sequence of the amplicon and
using the ﬂanking XbaI and XhoI restriction sites, the
ubiquitin-nsp12-His6 fusion gene (Ub-nsp12-CHis6) was
subcloned into vector pASK3 (IBA) and thereby placed
under the control of a tetracycline-inducible promoter.
This ruled out the known risk of potential contamination
with T7 RNA polymerase, as it can occur when using a T7
promoter to drive expression of other RdRps in bacterial
expression systems. Nsp12 active-site mutant D618A,
carrying an Asp618Ala substitution, was engineered via
site-directed mutagenesis according to the QuikChange
protocol (Stratagene), using primers SAV526 50-CCTTA
TGGGTTGGGCTTATCCAAAATGTG-30 and SAV527
50-CACATTTTGGATAAGCCCAACCCATAAGGA-30.
For nsp12 expression, the pASK3-Ub-nsp12-CHis6
plasmid was transformed to Escherichia coli C2523 cells
(New England Biolabs) together with the Ubp1 protease
expression plasmid pCGI (26), unless indicated otherwise
for particular experiments. Routinely, 250ml of Luria
Broth, containing ampicillin (50mg/ml) and chloram-
phenicol (34mg/ml), was inoculated 1:1000 with 3ml o/n
precultures and cells were grown at 37 Ct oO D 600 >0.7.
Subsequently, the cells were slowly cooled to room tem-
perature, tetracycline was added to a ﬁnal concentration
of 200mg/ml and the cells were further grown at 20 C for
another 16h. Cells were harvested by centrifugation,
washed once with ice-cold phosphate-buﬀered saline
(PBS) and stored at  20 C until protein puriﬁcation.
SARS-CoV nsp12 expression vectors pKM596-nsp12
(kindly provided by Dr. Isabelle Imbert and Dr. Bruno
Canard) and pET102-Thio-nsp12 (a kind gift of
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used to transform E. coli BL21(DE3) cells and expression
was performed using the auto-induction medium
ZYM-5052 (27).
Puriﬁcation of SARS-CoV nsp12-His
Cell pellets were thawed on ice, resuspended in binding
buﬀer (20mM HEPES pH 7.4, 500mM NaCl, 20mM
imidazole, 10% glycerol, 0.05% Tween-20 and 5mM
b-mercaptoethanol) and lysed by sonication. Cell debris
was removed by ultra-centrifugation at 20000g and the
cleared supernatant was incubated with Talon beads
(Clontech) for 2h at 4 C. The beads were washed three
times with 20vol of binding buﬀer, loaded onto spin
columns and ﬁnally the His-tagged protein was eluted
with 300mM imidazole in binding buﬀer. The eluate
was analyzed by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS–PAGE) and typically found
to be 80–85% pure. Subsequently, gel ﬁltration on
a Superdex 200 column (GE Healthcare) in 20mM
HEPES, 500mM NaCl, 5% glycerol, 5mM b-mercapto-
ethanol and 0.1% Tween-20 was used to improve purity
to  95%. To estimate the molecular mass of nsp12, a
standard curve for hydrodynamic elution was made
using chymotrypsinagen A, conalbumin, aldolase and
dextran blue (all purchased from GE Healthcare) as size
markers and ﬁtted to a linear equation (R
2=0.99).
After the gel ﬁltration step, the nsp12-containing frac-
tions were pooled, concentrated with Ultrafree 10-kDa
ﬁlter columns (Millipore) and dialyzed overnight against
1000 sample volumes of dialysis buﬀer (20mM HEPES
pH 7.4, 100mM NaCl, 0.1% Triton-X 100, 1mM DTT
and 50% glycerol) in cellulose tubing (SnakeSkin, Pierce).
Protein concentrations were determined using a Bradford
assay and a bovine serum albumin (BSA) standard curve,
and the puriﬁed protein was stored at  20 C. When using
expression vectors pKM596-nsp12 and pET102-Thio-
nsp12, protein puriﬁcation procedures were essentially
similar to those described above, except that amylose
resin (New England Biolabs) was used to bind the
pMK596-nsp12 product, which was eluted using a buﬀer
containing 10mM amylose instead of imidazole.
SDS–PAGE and western blotting
Cells were lysed in Laemmli’s sample buﬀer (28),
separated on 8% SDS–PAGE gels and either electro-
blotted to polyvinylidene ﬂuoride (PVDF) membrane
(GE Healthcare) or stained directly with Coomassie
G-250 according to standard protocols. Prior to incuba-
tion with a SARS-CoV nsp12-speciﬁc rabbit antiserum (a
kind gift from Dr. Mark Denison) (29), blot membranes
were blocked with 10% skimmed milk and 0.02% Tween-
20 in PBS. Blots were washed with 0.02% Tween-20
in PBS, incubated with a swine-anti-rabbit horseradish
peroxidase conjugate diluted in 5% skimmed milk,
0.02% Tween-20 and PBS, washed and subjected to
ECL Plus chemiluminescence detection (GE Healthcare).
Preparation of templates
RNA oligonucleotides and their DNA counterparts
SAV557R 50 -GCUAUGUGAGAUUAAGUUAU-30
and SAV481R 50-UUUUUUUUUUAUAACUUAAUC
UCACAUAGC-30, SAV555R 50- UUUUUUUUUUU
UUUUUUUUUAUAACUUAAUCUCACAUAGC-30
and SAV556R 50-UCUCUCUCUCUCUCUCUCUCAU
AACUUAAUCUCACAUAGC-30 were purchased from
Eurogentec, excised as a single band from 7M urea/15%
polyacrylamide gels, eluted overnight in deionized water
and desalted using NAP-10 columns (GE Healthcare).
To anneal RNA duplexes, oligonucleotide mixtures in
annealing buﬀer [20mM Tris–HCl pH 8.0, 50mM NaCl
and 5mM ethylenediaminetetraacetic acid (EDTA)] were
heat denatured, slowly cooled to room temperature and
subsequently puriﬁed from 15% nondenaturing poly-
acrylamide gels.
RdRp activity assays
To test the in vitro RdRp activity of SARS-CoV nsp12-
CHis6, 0.1mM of the protein (unless otherwise indicated)
was incubated at 30 C in the presence of 1mM template,
0.17mM[ a-
32P]ATP (0.5mCi/ml; Perkin-Elmer), 50mM
ATP (Roche), 20mM Tris–HCl (pH 8.0), 10mM
NaCl, 10mM KCl, 6mM MgCl2, 5% glycerol, 0.01%
Triton-X 100, 1mM DTT and 0.5U of RNaseOUT
(Invitrogen). Glycerol and NaCl were introduced with
the addition of enzyme due to their presence in the
nsp12 storage buﬀer. RdRp reactions were terminated
by adding an equal volume of 90% formamide, 50mM
EDTA pH 8.0, 0.01% bromophenol blue and xylene
cyanol. Reaction products were analyzed on 7M Urea,
20% polyacrylamide gels buﬀered with 1  TBE (90mM
Tris, 90mM H3BO3 and 2mM EDTA). Gels were run
for 5h at 2000V and analyzed using phosphorimaging.
Plates were scanned on a Typhoon variable mode
scanner (GE Healthcare) and products were quantiﬁed
with ImageQuant TL 7.0 (GE Healthcare). To calculate
the amount of [a-
32P]AMP incorporated from the
phosphorimager signal, a 10
 2–10
 5 dilution series of
the [a-
32P]ATP stock was spotted in triplicate on
Whatman ﬁlter and exposed alongside the PAGE gel of
interest. Using the standard curve, phosphorimager
counts were converted into the amount of label incorpo-
ration and kinetic traces were ﬁt to a linear function
with the MATLAB 2008b Curve Fitting Toolbox
(Mathworks).
Electrophoretic mobility shift assays
A dilution series of SARS-CoV RdRp in storage buﬀer
was incubated for 10min at room temperature with
0.2nM of
32P-labeled oligonucleotide SAV557R (see
above), in the presence or absence of the complementary
oligonucleotide SAV481R. Samples were then directly
loaded on to 8% acrylamide gels containing 5% glycerol
and 0.5  TBE and were run at 100V for 2h at 4 C. Gels
were dried on Whatman ﬁlter paper and bands were
quantiﬁed by phosphorimaging. Using the MATLAB
2008b Curve Fitting Toolbox, the percentage of RNA
Nucleic AcidsResearch, 2010, Vol.38,No. 1 205bound was ﬁt to the Hill equation RNAbound=
b*[nsp12]
n/(Kn
d+[nsp12]
n), where b is the upper binding
limit, [nsp12] is the nsp12 concentration, n is the Hill coef-
ﬁcient and Kd is the enzyme’s dissociation constant.
RESULTS
Stable expression and puriﬁcation of full-length
SARS-CoV nsp12
A PCR amplicon encoding SARS-CoV nsp12 was ﬁrst
cloned into T7 expression vector pET26-Ub-CHis6,
which provided the 932-aa viral protein with an
N-terminal Ub tag (76 amino acids) and a C-terminal
hexahistidine tag (Figure 1A). To avoid the known risk
of T7 RNA polymerase contamination when purifying
another RdRp using a T7 promoter-driven expression
system [like E. coli BL21(DE3)], the Ub-nsp12-CHis6
fusion gene was subsequently transferred to plasmid
pASK3, placing it under control of a tetracycline-
inducible promoter. Initially, the protease that was later
used to remove the Ub tag was not co-expressed and the
expression of the full-length Ub-tagged nsp12-CHis6 was
compared to that of variants containing either maltose
binding protein (MBP) or thioredoxin (Thio) as fusion
partner. As shown in Figure 1B and as also documented
in the previous work of Cheng et al. (24), expression
and puriﬁcation of nsp12 fusion proteins resulted in
the abundant and progressive fragmentation of the
protein. Based on their sizes in SDS–PAGE, the
cleavage products likely were the 64- and 39-kDa nsp12
degradation products as found by Cheng et al. (24)
when working with their GST-nsp12 fusion construct
(Figure 1B). Therefore, our results conﬁrmed and
extended the previously reported observations regarding
the instability of SARS-CoV nsp12 when expressed in
E. coli as part of a fusion protein.
In studies with the poliovirus (PV) RdRp (3D
pol), it was
previously shown that N-terminal foreign sequences, even
the addition of a single methionine residue, can have a
signiﬁcant impact on enzyme activity (26,30). Structural
studies subsequently revealed that a native N-terminus is
required for the proper folding of the RdRp’s ‘ﬁngers’
subdomain and the positioning of the 3D
pol active
Figure 1. Expression and puriﬁcation of the SARS-CoV nsp12. (A) Expression of nsp12 was performed in the presence of the ubiquitin (Ub)
protease Ubp1, which removed the N-terminal Ub fusion partner by cleaving after the LRGG signature that formed the junction between the Ub
and nsp12 moieties. This in vivo cleavage created the native nsp12 amino-terminus with the sequence SADAS. (B) Western blotting using an nsp12-
speciﬁc polyclonal antiserum identiﬁed a single band of the expected mass after puriﬁcation of the in vivo cleaved expression product. Isolation of
fusion proteins with diﬀerent N-terminal tags resulted in common patterns of degradation. Similar results were reported by Cheng et al. (24) for a
GST-nsp12 fusion protein. (C) Puriﬁed nsp12-CHis6 was readily visualized by Coomassie staining as a  106-kDa protein product, in line with the
expected mass. Inductions in the absence of Ubp1 expression, however, resulted in a mixture of full-length fusion protein and degradation products,
likely as a result of improper folding. No RdRp activity was observed for these preparations. (D) Gel ﬁltration analysis of puriﬁed nsp12 in assay
buﬀer showed a single peak, corresponding to a globular molecular weight of 140±10kDa, suggesting that only the monomeric form of nsp12 is
present under the conditions used.
206 Nucleic Acids Research, 2010,Vol. 38,No. 1site (30). These ﬁndings suggested to us that N-terminal
additions might also hamper the proper folding of the
SARS-CoV RdRp and could thus be the principal cause
of its subsequent degradation. We therefore co-expressed
the C-terminal Ub protease Ubp1 (26), which speciﬁcally
recognizes the cleavage site in our fusion protein that
is located between the Ub moiety and the N-terminus of
nsp12 (LRGG#SADAS). Proteolytic cleavage of the
fusion protein at this site liberated an nsp12-CHis6
product (Figure 1A), now containing its natural N-
terminus. The expression of the Ubp1 protease was
driven by the relatively weak constitutive ADH1
promoter (26). Hence, to ensure optimal release of
nsp12-CHis6 by the protease, induction of Ub-nsp12-
CHis6 expression was performed only in the middle or
late log-phase of bacterial growth. Induction at lower
densities or on-column cleavages performed with the
cleavable MBP and Thio fusion proteins resulted in sig-
niﬁcant amounts of degraded nsp12, which was inactive in
RdRp assays (data not shown).
As depicted in Figure 1B and C, the in vivo cleavage
product that we were able to routinely purify was of the
expected 106-kDa size (9) and was found to be stable, even
after multiple rounds of puriﬁcation and prolonged
storage at  20 C. Non-denaturing gel ﬁltration yielded a
single peak corresponding to a size of about 140±10kDa
as estimated by comparison to a standard curve (Figure
1E–F). This is diﬀerent from the calculated mass of
106kDa, but may be explained by, e.g. a very open or
nonglobular structure of the protein. Moreover, unex-
pected behavior in gel ﬁltration is not without precedent
for RdRps, as was, e.g. reported for the monomeric u6
RdRp P2 (31). Future structural studies involving electron
microscopy or crystallography will hopefully allow us to
address this question in more detail.
SARS-CoV nsp12 is a primer-dependent RdRp
+RNA virus replication may proceed through a variety
of scenarios, but essentially viral RdRps employ only two
fundamentally diﬀerent mechanisms during the ﬁrst step
of RNA synthesis: initiation can occur either de novo,
when the 30 hydroxyl group of the ﬁrst nucleotide essen-
tially is the ‘primer’ to which a second nucleotide is added,
or initiation can depend on an oligonucleotide or protein
primer (32). Imbert et al. (13) recently showed that the
CoV nsp8 subunit, a relatively small protein (22kDa)
that forms a hexadecameric complex with nsp7 (33), can
synthesize short oligonucleotides using poly(C) templates
or templates containing a 30 CCG/U motif. Although the
exact role of nsp8 remains to be studied in much more
detail, one of its proposed functions is that of an ‘RNA
primase’ (13). According to this hypothesis, and similar to
what has been documented for cellular DNA polymerases
(34), the oligonucleotide products of nsp8 activity would
serve as primers for the viral ‘main RdRp’, i.e. nsp12.
Some other observations were also consistent with the
possibility that the SARS-CoV main RdRp belongs to
the class of primer-dependent polymerases. First,
modeling of the structure of SARS-CoV nsp12 residues
400–900 suggested that the central domain of the protein
contains a G motif, a signature present in all primer-
dependent RdRps (23). Second, when using the unstable
GST-nsp12 fusion protein in combination with a poly(A)
template and a poly(U) primer, Cheng et al. (24) observed
a moderate RdRp activity in ﬁlter-binding assays.
Convincing evidence for the extension of an RNA
primer in vitro, however, has not been documented
thus far.
To qualitatively assess the polymerase activity of the
nsp12, we monitored the incorporation of nucleotides on
a well-deﬁned synthetic RNA template, which was pre-
dicted to lack secondary structures that could aﬀect the
enzyme’s processivity. This template (Figure 2A) consisted
of a 20-nt duplex and a 30 overhang of 10 uridylates, which
could serve as template during extension of the 20-mer
primer. As shown in Figure 2, primer extension was
revealed by both the incorporation of [a-
32P]ATP
(Figure 2B) and the extension of the
32P-labeled primer
(Figure 2C). The use of single-stranded or homopolymeric
[poly(U) or poly(C)] templates did not lead to signiﬁcant
incorporation of nucleotides (data not shown).
Based on sequence alignments of SARS-CoV nsp12
with RdRps of known structure, it was previously
concluded that the canonical aspartic acid residues
responsible for the coordination of the divalent cation in
the RdRp’s active site should be nsp12 residues 618, 760
Figure 2. SARS-CoV nsp12 primer extension assay and active-site
mutant. (A) Schematic showing the structure of the partially double-
stranded RNA template with 30 U10 stretch that served as template
for primer extension in the initial nsp12-based nucleotide incorporation
assay. (B) Comparison of the RdRp activity of wild-type nsp12 and
a D618A active-site mutant, which displayed minimal activity after
a 60-min incubation at 30 C. (C) A primer extension assay using a 50
32P-labeled primer and ATP conﬁrmed that wild-type nsp12, in contrast
to the D618A mutant, was able to elongate the 20-mer primer. The
slight reduction of input primer in the D618A lane probably resulted
from degradation by RNase activity. The D618A mutant showed
8±3% residual activity (mean of three independent experiments).
In the loading control (Figure 2B and C, lower panels) the two
nsp12 variants were visualized by silver staining of an SDS–PAGE gel.
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nidovirus-speciﬁc SDD motif (23,35–37). In other viral
RdRps, single or multiple substitutions of the equivalent
residues with alanine or asparagine were shown to change
or even abolish polymerase activity (38,39), depending
on the assay conditions used. For the PV 3D
pol, for
example, it was found that mutagenesis of the motif C
core sequence, changing it from GDD to GDN, was
detrimental in the presence of Mg
2+, but not when
Mn
2+ or Fe
2+ were provided as divalent cation (38). To
obtain an active site mutant that could be used as negative
control during further development of our assays, we engi-
neered nsp12 mutant D618A. As portrayed in Figure 2B
and C, the mutant protein displayed only 8±3% residual
primer extension activity in our assays (Figure 2B–D),
thus conﬁrming the nsp12-speciﬁc nature of the RdRp
activity described here and supporting the prior hypothe-
sis that this residue is a key player in the enzyme’s active
site. Further or complete knockdown of activity may
be obtained under slightly diﬀerent assay conditions
or in combination with substitution of other active site
residues, which remain to be tested in future studies.
Biochemical determinants of the in vitro activity of the
SARS-CoV nsp12
It is common practice to employ ﬁlter binding assays
during optimization of polymerase activity assays.
Although convenient and less time consuming than gel
analysis of reaction products, these assays merely reveal
incorporation of label, but do not provide direct informa-
tion on the length and integrity of the products. Therefore,
when exploring the eﬀects of diﬀerent reaction buﬀer
compositions, we consistently quantiﬁed and analyzed
[a-
32P]ATP incorporation using denaturing 20%
acrylamide gels. The standard assay buﬀer consisted of
20mM Tris–HCl (pH 8.0), 10mM KCl, 1mM DTT,
6mM MgCl2, 5% glycerol, 0.1% Triton-X 100 and
50mM ATP.
First, the inﬂuence of reaction temperature on RdRp
activity was tested within the range of 20–37 C. Activity
at 37 C was 40% higher than at 30 C, which is more
commonly used in RdRp assays (Figure 3A) (37,40–42).
However, a more detailed analysis revealed that this
increase largely stemmed from enhanced initiation of
primer extension rather than elongation, with the latter
being decreased by 35% as judged from the amount of
full-length product (primer+10, Figure 3B). Therefore,
all subsequent experiments were performed at 30 C.
Contrary to expectations however, the major extension
product never matched the length of the primer plus
10nt, suggesting that nsp12 generally terminates before
reaching the end of the primed poly(U) template. The
results obtained with other templates are discussed
subsequently.
It is well established that nucleic acid polymerases
utilize divalent cations, mostly Mg
2+, as cofactors to
bind and coordinate the incoming nucleotide during the
polymerization reaction (35,36). As shown in Figure 3C
and D, the activity of nsp12 was positively correlated with
the Mg
2+ concentration and reached its optimum at
6mM. Higher concentrations ( 20mM) ultimately abol-
ished activity (data not shown). The SARS-CoV RdRp
does not require Mn
2+ for RNA synthesis, as previously
reported for the nsp9-RdRp of the arterivirus equine
arteritis virus (EAV), a distant relative in the order
Nidovirales (37). In fact, the presence of Mn
2+ in an
RdRp assay utilizing a poly(U) template decreased the
ﬁdelity of the SARS-CoV nsp12 relative to Mg
2+ and
facilitated both transversional and transitional misincor-
porations (Figure 4). The speciﬁcity for the nucleotide’s
sugar moiety seemed not aﬀected, however, since
deoxyadenosine triphosphate (dATP) was not incorpo-
rated when using an RNA template in the presence
of Mn
2+. This discriminates the SARS-CoV RdRp
from, e.g. its PV equivalent, for which correct base
pairing was more important than the presence of a 20
hydroxyl group (40).
To establish the importance of pH, we tested SARS-
CoV RdRp activity in the pH range of 6.0–8.5. We
clearly observed an increase of nsp12 overall activity
with an optimum at pH 8.0 (Figure 3E), but diﬀerences
between pH 7.0 and 8.5 were marginal in terms of both
overall activity and amount of full-length product
produced (Figure 3F). Interestingly, pH 7.5 consistently
resulted in a signiﬁcantly larger amount of initiation
product, suggesting that higher pH values stimulate the
processivity of the enzyme.
In additional assays, we tested the eﬀect of monovalent
cations, bovine serum albumin and spermidine (data not
shown). No negative inﬂuence of potassium or sodium
ions was observed below a concentration of 50mM.
Neutral to slightly negative eﬀects were found for
both BSA (tested for 0–0.1mg/ml), which is known to
stabilize enzymes and reduce potential side eﬀects such
as absorbance to the plastic surface of the reaction tube
used. Finally, addition of spermidine, which binds to the
phosphate backbone of nucleic acids and is a known stim-
ulator of various polymerases, did not improve activity
in the tested concentration range up to 5mM.
RNA-binding properties of SARS-CoV nsp12
Our combined observations suggested that nsp12 is only
active in a primer-dependent fashion and may thus prefer
binding to double-stranded RNA (dsRNA). To determine
the aﬃnity of nsp12 for dsRNA and ssRNA we performed
electrophoretic mobility shift assays, in which we titrated
puriﬁed nsp12 in the presence of 0.2nM 50-
32P-labeled
RNA (Figure 5). Subsequently, the percentage of bound
template and the Hill equation (see ‘Materials and
Methods’ section) were used to derive the enzyme’s disso-
ciation constants (Kd). For dsRNA the Kd was calculated
at 0.13±0.03mM, whereas the Kd for ssRNA was
estimated to be 0.10±0.02mM.
Nsp12 nucleotide incorporation rates
For various viral RdRps, in vitro studies have deﬁned bio-
chemical properties that could not be determined or were
largely obscured in in vivo assays. Furthermore, following
the basic characterization of individual enzymes, the inter-
play with templates, cofactors and other subunits of the
208 Nucleic Acids Research, 2010,Vol. 38,No. 1viral enzyme complex can be addressed. Ultimately, this
should facilitate the in vitro reconstitution of the holo-
enzyme complex and the analysis of its interactions at
each step of viral replication and transcription. After the
puriﬁcation of active SARS-CoV nsp12 and exploration
of the reaction conditions, our subsequent step toward
such a future goal was to evaluate the rate of nucleotide
incorporation by the SARS-CoV RdRp. On a primed U10
template we found relatively poor incorporation rates
(1.2±0.4nM/min) and a major product that was 2–3nt
shorter than the expected full-length product (Figure 6A),
with product sizes displaying a similar Gaussian-like dis-
tribution as depicted in the graphs in Figure 3. On the
other hand, we also observed minor products that were
slightly longer than full length, suggesting slippage of the
polymerase at the end of the template. We did not detect
any terminal transferase activity on the templates used
(data not shown).
Figure 3. Biochemical determinants of SARS-CoV nsp12 activity. (A and B) Tests to determine the inﬂuence of temperature indicated that nsp12
incorporates ATP most eﬃciently at 37 C, although this eﬀect mainly stemmed from increased initiation. Based on these results, 30 C was taken as
the standard for subsequent experiments. (C and D) Titration of the Mg
2+ concentration showed that activity reaches its maximum at 6mM. (E and
F) The eﬀect of pH on RdRp activity was evident as well, with lower pHs limiting the activity of the enzyme. All reactions were incubated for 60min
at 30 C, unless otherwise indicated. Error bars in A, C and E represent standard error of the mean (n=3).
Nucleic AcidsResearch, 2010, Vol.38,No. 1 209Previously, Cheng et al. (24) reported that their
unstable GST-nsp12 fusion protein had limited reverse
transcriptase activity. In contrast to these prior results,
our nsp12 was not able to eﬃciently use dATP to extend
an RNA primer (Figure 4A and B) and a similar result
was obtained with a DNA primer (data not shown).
To test whether nsp12 was able to incorporate [a-
32P]
deoxyadenosine monophosphate (dAMP) when using
DNA templates, we employed a primed T10 template
similar to the RNA templates described above.
As shown in Figure 6B, nsp12 was capable of incorporat-
ing dAMP when incubated with a DNA template.
On average, a minor reduction ( 20%) in dAMP incor-
poration was observed in comparison to the activity on an
RNA template. The size distribution of products was
more diﬀerent, and showed signiﬁcantly less initiation
than on an RNA template (compare Figure 6A and B).
The incorporation rate of nsp12 increased dramatically
when we doubled the template length (VU20=27±3nM/
min, Figures 6C and 7), but we again observed a major
product that was 2nt shorter than the expected full-length
product. When the primed poly(U) template was changed
to a primed heteromeric (CU)10, nsp12 activity increased
further (V(CU)10=45±2nM/min) and reached a level
comparable to that obtained for other viral RdRps on
similar short templates (40). When the products of the
latter reactions were resolved by denaturing PAGE
(Figure 6D) they were found to be longer than template
length. Similar products extending beyond unit length
have been often observed when short templates were
Figure 4. Nucleotide incorporation ﬁdelity of nsp12. (A) Experimental
set-up of pulse-chase experiments with diﬀerent nucleotides and a
primed poly(U) template (see Figure 2A). The reactions were initiated
with a limiting concentration of [a-
32P]ATP to allow the incorporation
of a ﬁrst nucleotide and the formation of a stable polymerase-template
complex. Subsequently, after 10min, diﬀerent unlabeled nucleotides
were added to a ﬁnal concentration of 50mM to allow elongation
for another 30min. (B) SARS-CoV nsp12 allows only limited trans-
versional and transitional misincorporations. Interestingly, also in the
presence of dATP no signiﬁcant activity was observed, implying that
the SARS-CoV RdRp is capable of discriminating between ATP and
dATP. (C) Pulse-chase experiments in the presence of 6mM Mn
2+
show that manganese ions promote misincorporation of ribonucleotides
(both transversions and transitions). The selection against dATP
remained unaltered.
Figure 5. RNA binding aﬃnity of nsp12. (A) A ﬁxed concentration
(0.2nM) of radiolabeled dsRNA or ssRNA (data not shown) was
titrated with puriﬁed nsp12 and the complexes formed were separated
from unbound RNA on a native 8% polyacrylamide gel. (B) Free and
bound RNA were quantiﬁed and ﬁt to the Hill equation (see ‘Materials
and Methods’ section), resulting in Kd values of 0.13±0.3mM for
dsRNA and 0.10±0.2mM for ssRNA binding. R
2 values of these
Hill ﬁts were 0.97 and 0.98 for dsRNA and ssRNA, respectively.
Error bars represent standard error of the mean (n=3).
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pol (43) and their generation can be
explained by various mechanisms, such as distributive
slippage, processive slippage, template switching or
terminal transferase activity (43 and references therein).
Future research is expected to address these mechanisms
in more detail.
DISCUSSION
Detailed kinetic and stoichiometric information plays an
important role in explaining the molecular basis of RdRp-
catalyzed ribonucleotide incorporation, the associated
mutation rate of viral genomes and, consequently, RNA
Figure 6. Analysis of nucleotide incorporation by nsp12. (A) Reactions with 0.1mM nsp12, 1mM template and 50mM ATP were followed over time
and quenched with 50mM EDTA at the time points indicated. Gel analysis showed that, similar to the curves in Figure 3, the major accumulating
product is the primer (p) extended by 7nt (i.e. p+7) and not the expected full-length product of n+10. (B) To assess whether nsp12 was capable of
DNA-templated incorporation of dATP, reactions were performed as in Figure 6A, but now using a DNA template. The time course illustrates
robust [a-
32P]dAMP incorporation, implying that the SARS-CoV RdRp is able to utilize both RNA and DNA templates. The incorporation of
dAMP was 20% lower than that of AMP on an RNA template. (C) Time courses were additionally performed using an RNA template containing a
U20 template region. Similar to the shorter 10-nt template used in Figure 6A, the major product here was around 2nt shorter than the expected full-
length product. (D) Changing the single-stranded template from U20 to a heteromeric (CU)10 not only increased the nucleotide incorporation rate by
34%, but also the behavior of nsp12 on the template. Products of the expected full-length size (p+20) were observed, but also products longer than
the template, hinting at, e.g. template switching by nsp12. Future research will address this observation in more detail. In this reaction both 50mM
ATP and GTP were present. The gel image represents the top half of a 20% denaturing PAGE gel.
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standing of the diﬀerences between viral RdRps and
cellular polymerases is crucial in the design of speciﬁc
inhibitors of viral RNA synthesis and their subsequent
mechanistic characterization and optimization. Up till
now, all of the above information was particularly
limited, if not completely lacking, for the CoV RdRp,
due to enzyme insolubility, instability and low puriﬁcation
yields.
This study reports the ﬁrst successful expression and
puriﬁcation of stable, soluble SARS-CoV nsp12, thus
paving the way for its further biochemical characteriza-
tion. Using a two-step procedure, the protein was puriﬁed
to near homogeneity, as conﬁrmed by SDS–PAGE and
non-denaturing gel ﬁltration. We found that even a
single-step puriﬁcation scheme could produce an enzyme
preparation that combined speciﬁc activity with reason-
able purity (>80–85%). Of particular importance in our
expression protocol was the co-expression of the Ubp1
protease that mediated the in vivo removal of the
N-terminal Ub tag (Figure 1A) (26). Apparently, similar
to PV 3D
pol (30), SARS-CoV RdRp does not tolerate
additional amino acids at its N-terminus, likely because
they induce an unstable and largely inactive fold. Because
of the observed sensitivity to N-terminal fusions, it is
tempting to speculate that the processing of the pp1ab
cleavage generating the nsp12 N-terminus is of great
importance for proper folding and activity in vivo as
well. In line with this notion, it was reported that for the
related group 2 CoV mouse hepatitis virus (MHV) this
cleavage site indeed is indispensable for virus replication
(44). It still remains to be tested whether there is any eﬀect
of the C-terminal His-tag on the activity of the enzyme
used in this study.
The SARS-CoV nsp12 is a relatively large protein
(932-amino-acid residues), e.g. much larger than the well
described RdRps of HCV (591 amino acids) and PV (461
amino acids), and may have, in addition to the C-terminal
RdRp domain, other functional or contributing domains
in its still uncharacterized N-terminal domain(s).
Previously, the PV and HCV RdRps were demonstrated
to bind RNA with Kd values of 2–10mM (45) and  3mM
(46), respectively. Our data suggest that SARS-CoV nsp12
binds RNA with slightly higher aﬃnity for both dsRNA
and ssRNA (Kd 0.1mM). The relatively similar aﬃnities
for dsRNA and ssRNA suggest that the lack of de novo
initiation may largely be due to a relatively open structure
and the absence of a conserved priming loop in the pre-
dicted thumb subdomain (23). The latter structural
element, a b-hairpin in, e.g. hepatitis C virus (HCV)
NS5B, is present in many known de novo initiating
RNA polymerases. Canonically, it functions by partly
obstructing the template binding cleft and is believed to
be essential for association with the single-stranded 30 end
of the template RNA (23,47,48).
Contrary to previous GST-pull downs performed for
nsp12 (49) and data obtained for other RdRps such as
the PV 3D
pol—which was reported to form multimers
and even lattices (45)—we were not able to establish
nsp12 multimerization using non-denaturing gel ﬁltration.
Although this suggests that SARS-CoV RdRp exists
predominantly as monomer under the conditions used
here, it is likely that nsp12 binds to various other viral
replicase subunits (50) and cellular cofactors (51) in vivo.
The CoV holo-enzyme complex formed in this manner
may have more ﬁnely tuned characteristics than docu-
mented in this study. In addition, it remains to be tested
whether the C-terminal hexahistidine tag interferes with
multimerization. Clearly, these and other questions
should be addressed in more detail in future studies.
Upon binding to template and primer, we found nsp12
to have reproducible nucleotide incorporation rates on
the templates tested, but incorporation depended signi-
ﬁcantly on the length of the template. Furthermore, on
heteromeric templates the SARS-CoV RdRp also per-
formed better and reached incorporation rates in the
same order (>nM/min) as the model polymerases from
PV and HCV, when correcting for enzyme and template
concentrations (40,52). In addition, the SARS-CoV nsp12
is also active on a DNA template, which may greatly
facilitate further investigations in view of the superior
stability of DNA templates and the fact that various
other SARS-CoV enzymes (17,33,53) have documented
aﬃnity for DNA as well. It remains to be tested whether
SARS-CoV nsp12 is also active on a longer single-
stranded template, e.g. RNA templates based on the
terminal sequences of the viral genome, and whether it is
able to traverse the RNA secondary structures present in
such a molecule. Taken together, our data suggest that our
present puriﬁcation scheme and assay constitute a
concrete starting point for further biochemical exploration
of the SARS-CoV RdRp and nsp12 targeted inhibitor
development.
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